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and En
giore P
mfraquAbstract—The reference standard for assessing transjugular intrahepatic portosystemic shunt (TIPS) function is
venography with portosystemic pressure gradient (PPG) measurement. This procedure is invasive and expensive;
thus, we assessed the feasibility, reproducibility and diagnostic accuracy of color-Doppler ultrasound (CDUS)
and spleen and liver stiffness (LS) measurements for identifying TIPS dysfunction. Twenty-four patients (15
undergoing TIPS placement and nine undergoing TIPS revision) consecutively underwent CDUS examination
and LS and spleen stiffness (SS) determination by transient elastography (TE) and point shear-wave elastogra-
phy (pSWE). All parameters were taken before TIPS placement/revision (115 d before) and 24 h after, just
before revision by venography. pSWE inter-observer agreement was assessed by intra-class correlation coeffi-
cient (ICC). CDUS and elastographic data were correlated (Pearson coefficient) with pressure gradients (hepatic
venous pressure gradient [HVPG], PPG). Main determinants of TIPS dysfunction were investigated by linear
regression. Forty-nine paired examinations were performed in total: 49 (100%) SS reliable measurements by
pSWE and 38 (88%) by TE. The ICC for pSWE values was 0.90 (95% confidence interval [CI] 0.81‒0.94). SS val-
ues significantly correlated with HVPG and PPG (R = 0.51, p = 0.01). The area under the Receiver-Operating
Characteristic (AUROC) curve of SS for diagnosing TIPS dysfunction was 0.86 (95% CI 0.70‒0.96) using a 25
kPa cutoff. At multivariate analysis, the flow direction of the intrahepatic portal vein branches and SS values
were independently associated to TIPS dysfunction. The intrahepatic portal vein branches flow direction and SS
value are two simple, highly sensitive parameters accurately excluding TIPS dysfunction. SS measurement by
pSWE is feasible, reproducible and both positively and significantly correlates with HVPG and PPG values. (E-
mail: mfraquelli@yahoo.it) © 2020 The Author(s). Published by Elsevier Inc. on behalf of World Federation
for Ultrasound in Medicine & Biology. This is an open access article under the CC BY-NC-ND license.
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Color-Doppler ultrasound.INTRODUCTION
The transjugular intrahepatic portosystemic shunt (TIPS)
is an established procedure in the treatment of portalddress correspondence to: Mirella Fraquelli, Gastroenterology
doscopy Unit, Fondazione IRCCS Ca’ Granda Ospedale Mag-
oliclinico, Via F. Sforza 35, 20122 Milan, Italy. E-mail:
elli@yahoo.it
1641hypertension complications, including bleeding from
esophageal varices, refractory ascites, hepatic hydrotho-
rax and hepatorenal and hepatopulmonary syndromes
(Fagiuoli et al. 2017). TIPS placement successfully
reduces the portosystemic pressure gradient (PPG) in
more than 90% of cases (R€ossle et al. 1994; Cello et al.
1997; Sanyal et al. 1997). However, TIPS dysfunction,
1642 Ultrasound in Medicine & Biology Volume 46, Number 7, 2020defined as a PPG of 12 mm Hg (Garcia-Tsao et al. 1985;
Casado et al. 1998), is a common short- and mid-term
complication of the procedure and leads to recurrence of
the portal hypertension complication. When promptly
identified, shunt thrombosis or stenosis may be success-
fully treated before the recurrence of gastrointestinal
bleeding or ascites; thus, these patients require close
follow-up to detect and correct TIPS dysfunction. There
are no consensus guidelines or protocols for the manage-
ment of post-TIPS placement, and even the timing of
screening has not yet been standardized.
Currently, venography and pressure measurement
are the reference standards for assessing TIPS dysfunc-
tion, but they are invasive and expensive. Therefore, in
many centers venography is used only as a secondary
test, and Doppler ultrasound (US) is usually the primary
tool used for screening TIPS dysfunction because it is
non-invasive, readily available, repeatable and relatively
low-cost compared with other imaging modalities. No
consensus exists about the optimal sonographic screen-
ing protocol, and many different US parameters have
been applied to assess the patency and function of TIPS
with variable results (Chong et al. 1993; Ferral et al.
1993; Longo et al. 1993; Surratt et al. 1993; Feldstein
et al. 1994; Foshager et al. 1995; Kanterman et al. 1997;
Abraldes et al. 2005). Despite the number of studies that
assessed the accuracy of color-Doppler ultrasound
(CDUS) in the evaluation of TIPS patency, US parame-
ters are not adequately standardized yet.
Recently, several non-invasive elastographic techni-
ques have been developed and ascertained for accuracy in
assessing the severity of liver fibrosis and portal hyperten-
sion in patients with chronic liver diseases. Recently, a
rapid change of liver stiffness (LS) has been demonstrated
after variceal ligation and TIPS implantation (Piecha et al.
2018). However, on considering the promising results of
spleen stiffness (SS) in the assessment of portal hyperten-
sion (Calvaruso et al. 2013; Sharma et al. 2013; Fraquelli
et al. 2014; Singh et al. 2014; Stefanescu et al. 2014;
Wong et al. 2019), thanks to its good correlation with
hepatic venous pressure gradient (HVPG) values (Colec-
chia et al. 2012; Sharma et al. 2013), in the last few years,
some authors have examined the variations of spleen elas-
tography in patients undergoing TIPS placement and
hypothesized that this parameter might have a useful pre-
dictive value in determining TIPS function. In particular,
two previous preliminary studies (Gao et al. 2012; Ran
et al. 2013) showed that SS measured by Acoustic Radia-
tion Force Impulse (ARFI) has a significant correlation
with portal vein pressure and that the reduction in PPG
after TIPS correlates with the reduction of SS. A further
study (Gao et al. 2016) proved the application of splenic
shear-wave elastography in monitoring TIPS function dur-
ing a 12-mo follow-up. All the patients showed SSreduction after a successful revision of TIPS. Interestingly,
in the study by Novelli et al. (2015), after the TIPS place-
ment and effective reduction of PPG below 12 mm Hg,
the SS value decreased in 58% of patients. At variance, in
the remaining 42% of the patients SS increased in spite of
lower portal pressure when the competitive internal shunts
were embolized. The authors speculated that this finding
suggests a potential risk of recurrent variceal bleeding.
More recently, two prospective Italian and Chinese
studies (De Santis et al. 2018; Han et al. 2017) and a retro-
spective German study (Buechter et al. 2018) have showed
that SS measured by ARFI and transient elastography
(TE), respectively, positively correlates with pre-TIPS
HVPG values and significantly decreases after TIPS. In
addition, Attia et al. (2019) have demonstrated that SS is
superior to LS (both measured by ARFI and Child-Pugh
score) as a non-invasive surveillance tool for evaluating
patients with clinically significant portal hypertension
(HVPG10 mm Hg) before TIPS.
All these studies, albeit conducted on small num-
bers of patients, suggest that SS may be a predictive
marker of TIPS status: SS decreases because of portal
pressure reduction and its measurement can complement
conventional sonography for patients undergoing TIPS.
None of the previous studies has simultaneously
assessed the role of CDUS and elastographic parameters.
Thus, the aim of our study was to assess the accuracy of
CDUS parameters and LS and SS, as assessed both by
TE and ARFI (point shear-wave elastography [pSWE])
in the evaluation of TIPS function. In greater detail, the
aims of the present study were:
▪ To assess the feasibility and reproducibility of
splenic pSWE in patients undergoing TIPS place-
ment or revision;
▪ To measure any change of LS and SS after TIPS
placement or revision;
▪ To evaluate the correlation between CDUS or elasto-
graphic findings and HVPG and PPG values before
and after TIPS placement;
▪ To assess the diagnostic estimates of CDUS and LS
and SS for the identification of TIPS dysfunction and
to identify any variables independently associated
with TIPS dysfunction.MATERIAL ANDMETHODS
The experimental protocol was approved by the
local institutional review board (IRB), and the informed
consent for the study was obtained from all the patients
in accordance with the World Medical Association’s
2008 Declaration of Helsinki: Ethical Principles for
Medical Research Involving Human Subjects. The pri-
vacy rights of patients were always observed.
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All patients referred for TIPS and portal hyperten-
sion complications to the hepatology unit of our hospital
from January 2017 to June 2018 were consecutively
enrolled over an 18-mo period. The study protocol was
approved by the local ethics committee, and all the
patients gave their written informed consent.
All the patients underwent CDUS examination,
liver and splenic measurement by pSWE and TE 115 d
before TIPS placement or revision and 24 h after, just
before revision by venography; the pSWE measurements
were performed by two investigators (M.F. and M.G.)
well trained in elastographic techniques. TE was per-
formed by another expert operator (B.C.).
The inclusion criteria were all indications to TIPS
placement or TIPS revision, given by the multidisciplin-
ary team. The exclusion criteria were all conditions that
did not meet the inclusion criteria. Demographic, clini-
cal, biochemical, CDUS and elastographic data were col-
lected for every patient.
CDUS examinations
A physician with at least 3 y experience in sonogra-
phy performed all the sonographic examinations using
an iU22 US scanner (Philips Healthcare, Bothell, Wash-
ington, USA). In all the patients, we measured the spleen
size, the direction and flow velocity of the main portal
vein. In the patients with TIPS, we evaluated the direc-
tion of flow (hepatopetal vs. hepatofugal) of the main
portal vein and intrahepatic portal vein branches (hepato-
petal vs. hepatofugal), and we measured the flow veloc-
ity in the shunt at two sites (proximal and distal).
The CDUS parameters analyzed and considered as
pathologic were: the presence of a hepatofugal direction
of flow in the main portal vein, a flow velocity of the
main portal vein slower than 30 cm/s, a hepatopetal direc-
tion of flow in the intrahepatic portal vein branches and a
flow velocity in the TIPS<90 cm/s and/or>190 cm/s.
Liver pSWE
Liver pSWE was performed by two investigators (MF
and MG), expert in elastographic techniques and blind to
radiologic data. LS was measured using iU22 US equip-
ment with a convex broadband probe and the ElastPQmod-
ule. This technique generates shear waves in the liver using
radiation force from a targeted US beam. The US machine
monitoring the shear-waves propagation by a Doppler-like
US technique, ultimately measures the shear-wave velocity,
which is displayed in m/s or in kPa through Young modu-
lus E = 3 (vS2.q), where E is Young modulus, vS is the
shear-wave velocity and q is the tissue density. The meas-
urements were performed in the right lobe of the liver
through intercostal approach, with the patient lying supine
with the right arm in maximal abduction. Using a real-timeB-mode picture, the rater selected a vessel-free area at least
1.5 cm below Glisson capsule, where a fixed region of
interest (ROI) sized 0.5 cm x 1.5 cm was outlined by mov-
ing a trackball. The maximum penetration depth of pSWE
was 7 cm. The patients were instructed to hold their breath
in an indifferent position while the rater pressed a button
that launched the data acquisition. Only the examinations
with at least 10 validated measurements expressed in kPa
were considered reliable. In addition, the median value of
successful measurements was considered as representative
of the LS in any given patient only if the inter-quartile
range (IQR) of all validated measurements was less than
30% of median values.
Splenic pSWE
In the 29 paired examinations, the splenic pSWE
measurements were performed by two investigators (M.F.
and M.G.). An iU22 US scanner with the shear-waves gen-
eration capability was used to measure SS by a calculated
Young modulus estimate based on the shear-wave velocity.
The patient was placed in the right lateral decubitus
position to measure SS through the intercostal approach.
The splenic pSWE was measured as the patient held his
or her breath for a few seconds. The splenic pSWE was
sampled in the splenic parenchyma at a 2-cm depth from
the splenic capsule in a region free of visible vessels. The
size of the ROI for measuring splenic pSWE was 10 cm x
5 mm. The mean shear-wave velocity value of the spleen
was calculated as the average of these measurements.
The splenic pSWE was measured twice: once 115
d before TIPS placement or revision and then the day after
both procedures. For 7 patients referred for TIPS revision,
we could not perform sonographic and elastographic
measurements after TIPS revision because the patients
were non-compliant or had not given their consent to
examination.
Liver TE
The measurements were performed by an indepen-
dent investigator (B.C.) who had already gained 3 y
experience in TE measurements and was blind to clini-
cal, US and elastographic data. Excellent intra- and
inter-observer agreement on TE measurement has
already been reported in the literature (Fraquelli et al.
2007; Boursier et al. 2008).
TE was performed on patients in a fasting state on
the same day after pSWE. The medium probe was used
for all the patients. The right lobe of the liver was targeted
through the intercostal space access while the patient was
lying in the dorsal decubitus position with the right arm in
maximal abduction. The rate of successful measurements
was calculated as the ratio between the number of valid
measurements and the total number of measurements.
The results were expressed as a median value of the total
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10 validated measurements and a success rate of at least
60% were considered reliable. In addition, the median
value of successful measurements was considered as rep-
resentative of LS in any given patient only if the IQR of
all the validated measurements was less than 30% of the
median values (Ziol et al. 2005).
Splenic TE
The procedures were performed by the same
investigator who had performed LS measurements (B.
C.) and was blind to pSWE data. S-TE was per-
formed after the scanning of the splenic parenchyma
through left-hand side intercostal space access, while
the patient lay in the ventral decubitus position with
his or her left arm in maximal abduction. The
medium probe was used for all the patients. The tip
of the probe transducer was placed in a previously
US targeted point, where the spleen parenchyma had
previously been identified. The adequate total number
of valid measurements, success rate and IQR were
the same as for the LS-TE examination. The lack of
valid shots was defined as SS-TE failure.
The investigator who performed splenic TE had
received prior training of 50+ S-TE measurements.
Venography, TIPS placement and TIPS revision
TIPS placement was performed in the interventional
unit of the department of radiology. A polytetrafluoro-
ethylene (PTFE)-covered stent (10-mm diameter Gore
Viatorr TIPS Endoprosthesis, Putzbrunn, Germany) was
placed between the right hepatic vein and right portal
vein in 15 patients. In a patient affected by Budd-Chiari
syndrome a transcaval shunt was used. The HVPG
before TIPS placement and the PPG after it were mea-
sured. The HVPG was determined by the measurement
of the pressure gradient between the wedged and free
hepatic venous pressures. The PPG was determined by
subtracting the inferior vena cava pressure value from
that of the portal vein pressure. Good hemodynamic
response was defined as a reduction of PPG down to
less than 12 mm Hg. In addition to TIPS placement, the
radiologist looked for the presence of possible competi-
tive portosystemic collateral veins with the aim of possi-
ble embolization.
Venography and PPG measurement were performed
on the patients undergoing TIPS revision.
TIPS dysfunction was considered as the presence of
venographic morphologic defect (intra-stent thrombosis
or stenosis) or when PPG was greater than or equal to
12 mm Hg. In these cases, radiologic revision, using per-
cutaneous transluminal angioplasty (PTA) balloons and/
or with additional stents, was performed. The PPG was
again measured after TIPS revision.Statistical Analysis
The quantitative variables (i.e. the velocity of the main
portal vein, intra-shunt proximal and distal velocity, liver
and spleen TE, liver and spleen pSWE and HVPG or PPG)
were expressed as mean value and standard deviation. The
inter-rater agreement of the splenic pSWE measurements
was evaluated by intra-class correlation coefficient (ICC).
Agreement was classified as poor (ICC = 0.00‒0.20), fair
(ICC = 0.20‒0.40), moderate (ICC = 0.40‒0.75) or substan-
tial to excellent (ICC > 0.75) (Bland and Altman 1986;
Fleiss 1986). The linear correlation between liver and
splenic pSWE and HVPG or PPG in patients with and with-
out TIPS dysfunction was evaluated by the Pearson correla-
tion coefficient (r).
The diagnostic accuracy of liver and splenic pSWE
in identifying TIPS dysfunction was assessed using
venographic and/or manometric data as the reference
standard. Sensitivity, specificity and positive and nega-
tive likelihood ratios (LR+ and LR) with 95% CI were
calculated for every parameter.
Receiver-operating characteristic (ROC) curve analy-
sis was performed, and the area under the ROC curve
(AUROC), along with 95% CI, was calculated as an indica-
tor of the overall accuracy of liver and splenic pSWE. As to
pSWE, we arbitrarily decided to use the measurement per-
formed by the first rater. For TIPS dysfunction, the value
maximizing the Youden index (sensitivity + 1 specificity)
was selected as the best cutoff value. The obtained cutoff
values were used to assess the splenic pSWE inter-observer
clinical concordance. The agreement between the two oper-
ators in classifying each patient above or below the obtained
cutoff values (i.e. in predicting TIPS function vs. dysfunc-
tion) was calculated by the Cohen kappa coefficient.
Finally, logistic regression analysis was performed to
identify the variables significantly associated with TIPS
dysfunction. CDUS parameters (velocity in the main portal
vein, intrashunt proximal and distal velocity, flow direction
in the intrahepatic portal branches) and SS by pSWE were
considered potential predictors of TIPS dysfunction.
Firstly, univariate analysis was carried out on each of the
above reported determinants. Subsequently, only the varia-
bles that had resulted as statistically significant at univariate
analysis were considered for multivariate analysis.
The study was conducted and written according to
the Standards for Reporting Studies of Diagnostic Accu-
racy. All statistical analyses were performed with SAS
statistical software (release 9.4; SAS Institute Inc., Cary,
North Carolina, USA).RESULTS
Thirty-four consecutive patients referred for TIPS
placement or revision were initially recruited. Five of
these patients did not undergo TIPS placement (two
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to a different city or country and 1 patient did not con-
sent to the procedure). Five other patients who under-
went early TIPS as rescue therapy for acute bleeding
owing to gastroesophageal varices were also excluded.
The remaining 24 patients were enrolled in the study:
15 patients underwent TIPS placement, and 9 patients under-
went TIPS revision. The main indications for TIPS place-
ment were refractory ascites (7 patients) and variceal
bleeding (6 patients). A patient underwent TIPS placement
because of both refractory ascites and variceal bleeding and
another for refractory ascites in Budd-Chiari syndrome. Indi-
cations for TIPS revision in 9 patients included scheduled
invasive revision at 1 y in 4 patients and clinical evidence of
shunt dysfunction in 5 patients (persistence of ascites or large
varices). The etiology of portal hypertension and the other
clinical and demographic characteristics of the 24 patients
enrolled are summarized in Table 1.
On the 24 enrolled patients, the following were
performed:
▪ On the 15 patients who underwent TIPS placement,
we performed 15 CDUS and elastographic examina-
tions (considered as index examinations) before and
15 index examinations 1 d after TIPS placement;
▪ On the 9 patients who underwent TIPS revision, we per-
formed 11 index examinations before TIPS revision
(1 patient underwent three TIPS revisions, so we per-
formed three index examinations before each TIPSTable 1. Main clinical and demographic characteristics of 24
consecutive patients who underwent color-Doppler ultrasound
examination and liver and spleen stiffness measurement by
point shear-wave elastography and transient elastography
Patients characteristics
Male, n (%) 17 (71)
Age, median, range (y) 58 (22‒80)
BMI (kg/m2) 25 (19.7‒35)
Etiology of portal hypertension, n (%)
ETOH 8 (33)
HCV 3 (12)
NASH 3 (12)
Budd-Chiari syndrome 3 (1)
PBC 2 (8)
Mixed 5 (21)
Child-Pugh, n (%)
A, B, C 5 (21), 18 (75), 2 (13)
Indication for TIPS placement, n (%)
Refractory ascites 7 (47)
Secondary prophylaxis of varices bleeding 6 (40)
Both, other 2 (13)
PPG value, n (%)
12 mm Hg 13 (38)
<12 mm Hg 21 (62)
BMI, body mass index; ETOH, ethanol; HCV, Hepatitis C virus;
NASH, non alcoholic steatohepatitis; PBC Primary biliary cholangitis;
PPG, portosystemic pressure gradient; TIPS, transjugular intrahepatic
portosystemic shunt.revision) and only two index examinations after TIPS
revision because seven patients withdrew their consent.
Overall, we carried out 49 paired examinations (i.e.
49 pairs of data consisting of each non-invasive exami-
nation result being coupled with the venographic exami-
nation result: 34 pairs from patients who had TIPS
already in place and 15 from patients before TIPS place-
ment). The analysis of the study was conducted by exam-
ining the data of these procedures.
A flow chart of the patients and study design is pro-
vided in Figure 1.
Feasibility and reproducibility of liver and spleen TE
and pSWE measurements
Among the 49 paired examinations, there were 14
(28%) indeterminate liver TE measurements, of which
10 were failures (no valid data) and four were unreliable
measurements (not valid for SR <60% and/or IQR
>30%). The reason of such indeterminate results was
related to the presence of ascites. There were 11 (22%)
indeterminate SS measurements; half of those cases
were related to failures and the other half to unreliable
examinations. In such cases, the main reason of unsuc-
cessful results was again related to the presence of asci-
tes or to a high body mass index.
All the 49 liver and splenic pSWE measurements
were reliable in spite of any presence of ascites (0% of
unreliable results). Regarding the reproducibility of
splenic pSWE measurements, splenic pSWE was per-
formed by two blinded operators for 29 examinations,
and their inter-observer agreement, expressed as ICC,
was 0.90 (0.81‒0.94) (Fig. 2).
Correlation between liver and spleen elastography
values and HVPG/PPG values
In the whole group of 49 examinations, LS values
did not significantly correlate with HVPG/PPG values
(r = 0.19, p = NS, not significant) whereas SS values sig-
nificantly and positively correlated with HVPG/PPG val-
ues (r = 0.51, p = 0.01) (Fig. 3).
Among the 17 patients who underwent CDUS and
elastographic examinations before and after TIPS placement
(15 patients) or TIPS revision (2 patients), statistically sig-
nificant differences in PPG (p = 0.05), portal vein velocity
(p = 0.033) and splenic pSWE measurements (p = 0.019)
were observed before and after TIPS placement or TIPS
revision, while there was no statistically significant differ-
ence in LS as measured by pSWE (p = 0.888) (Fig. 4).
Venographic, CDUS and elastographic data referring to
TIPS dysfunction
Among the 24 patients who underwent TIPS place-
ment or TIPS revision, PPG decreased below 12 mm Hg
Fig. 1. Patients flow chart. The image explains in detail the phases of the study.
Fig. 2. Spleen stiffness inter-observer agreement. The graph represents the inter-observer agreement of the spleen stiff-
ness, measured by point shear-wave elastography (pSWE), between the two operators in the overall cohort of the 24
patients.
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Fig. 3. Correlation between elastography data and hepatic venous pressure gradient (HVPG). The graphs represent the
correlation between liver or spleen elastography values, measured by point shear-wave elastography (pSWE) (kPA), and
the HVPG/PPG values (mm Hg).
Fig. 4. Hepatic venous pressure gradient (HVPG) and elastographic measurements before and after transjugular intrahe-
patic portosystemic shunt (TIPS) placement or revision. The graphs represent the mean portal pressure gradient (mm
Hg) or the liver or the splenic stiffness (kPa) measured by point shear-wave elastography (pSWE) in 17 patients before
and after TIPS placement or TIPS revision.
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remained between 13 mm Hg and 15 mm Hg.
Among the 34 TIPS revision cases, venographic
examination showed 21 cases of TIPS function (61.7%)
in which no morphologic defects were evidenced by
venography and by PPG value of <12 mm Hg, and 13
cases of TIPS dysfunction (38.2%). The PPG values
were 12 mm Hg in 4 cases, there was shunt stenosis or
thrombosis in 3 cases, and both shunt stenosis and
thrombosis occurred in 6 cases.
Diagnostic accuracy of mean portal vein velocity and liver
and spleen elastography in predicting TIPS dysfunction
The 24 patients enrolled in our study underwent a
total of 34 paired examinations to evaluate TIPS func-
tion. Every paired examination included the index test
(which comprised CDUS, liver and spleen elastography)
and the reference standard, which comprised venographyand PPG measurement. In 21 cases the reference stan-
dard demonstrated TIPS function, whereas in the remain-
ing 13 cases it showed TIPS dysfunction (Table 2).
These 13 examinations included four examinations
where PPG was 12 mm Hg, three examinations where
thrombosis or stenosis of the stent was detected (and
then treated with PTA balloons and/or stents) and six
examinations showing both venographic defect and PPG
of 12 mm Hg.
At univariate analysis, the variables that were sig-
nificantly related to TIPS dysfunction were: the hepato-
petal blood flow direction in the intrahepatic portal vein
branches (p = 0.004) and high SS values (Table 3 pro-
vides the diagnostic performance values). In particular,
by applying a 25 kPa cutoff value to predict TIPS dys-
function, sensitivity was 86%, specificity was 92%, LR+
was 11, LR was 0.10 and the AUROC was 0.86 (95%
CI 0.70‒0.96).
Table 2. Color-Doppler ultrasound and elastographic variables correlated to transjugular intrahepatic portosystemic shunt
dysfunction
Parameters TIPS Functioning
(total n = 21 patients)
TIPS Dysfunction
(total n = 13 patients)
p Value
Hepatopetal portal flow direction 19 8 0.04
Portal vein maximal velocity (cm/s) 7 3 0.52
Shunt maximal flow velocity (proximal) (cm/s) 6 1 0.14
Shunt maximal flow velocity (distal) (cm/s) 6 3 0.72
Hepatofugal flow direction in the intrahepatic portal veins branches 20 4 0.0006
Liver stiffness pSWE (kPa) (mean § SD) 17.5 § 12.5 22.9 § 12.5 0.22
Spleen stiffness pSWE (kPa) (mean § SD) 18.1 § 9.3 32.7 § 9.1 0.0001
Portal vein maximal velocity (mean § SD) 35.2 § 17.3 22.5 § 11.2 0.02
pSWE, point shear-wave elastography; SD, standard deviation. TIPS, transjugular intrahepatic portosystemic shunt.
Table 3. Operative characteristics of color-Doppler ultrasound and elastographic parameters significantly related to transjugular
intrahepatic portosystemic shunt dysfunction for 24 consecutive patients who underwent color-Doppler ultrasound, point shear-wave
elastography and venography
Variable Cutoff Sens (%) Spec (%) LR+ LR AUROC (95% CI)
Portal vein velocity (cm/s) 19 90 61 2.3 0.15 0.75 (0.57‒0.88)
Intrahepatic portal vein branches flow direction
(hepatopetal vs. hepatofugal)
- 70 95 14 0.3 -
Spleen stiffness (kPa) 25 86 92 11.1 0.10 0.86 (0.70‒0.96)
AUROC, area under the receiver-operating characteristic curve; CI, confidence interval; LR+, positive likelihood ratio; LR, negative likelihood
ratio, Sens, sensitivity; Spec, specificity.
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nificantly related to TIPS dysfunction were: the blood
flow direction of intrahepatic portal vein branches
(p = 0.02) and SS values (p = 0.01). The overall diagnostic
accuracy of the model was excellent (AUROC = 0.90).DISCUSSION
The role of TIPS in the treatment of portal hyper-
tension complications is well established. Placing PTFE-
coated stents, instead of bare metal ones, has signifi-
cantly improved the long-term patency of TIPS and
decreased the rate of TIPS dysfunction from 44% to
15% (Boyer and Haskal 2005). Despite that, because
TIPS dysfunction is often asymptomatic, an accurate
screening test is needed to confirm shunt patency. The
reference standard to assess TIPS function is venography
with PPG measurement: evidence of a reduction of PPG
to less than 12 mm Hg is considered the pressure target,
especially with patients who have bleeding as an indica-
tion (Fagiuoli et al. 2017).
An ideal non-invasive screening tool should have
high sensitivity and negative predictive values to rule
out patients with well-functioning TIPS, with a good
degree of confidence, and safely to spare these patients
venography. CDUS has been extensively studied for
measuring intra-stent and main portal vein flow veloci-
ties and flow direction in the intrahepatic portal veinbranches, which has been shown to be a reliable qualita-
tive indicator of TIPS malfunction (Fagiuoli et al. 2017).
In addition, recent data has indicated the promising
role of SS in the assessment of portal hypertension thanks
to its good correlation with HVPG values. Several studies
have demonstrated the good diagnostic accuracy of SS,
particularly in ruling out the presence of esophageal vari-
ces (Boyer and Haskal 2005; Colecchia et al. 2012; Cal-
varuso et al. 2013; Sharma et al. 2013; Fraquelli et al.
2014). More recently, several preliminary studies (Gao
et al. 2012; Ran et al. 2013; Novelli et al. 2015; Gao et al.
2016; Han et al. 2017; De Santis et al. 2018; Buechter
et al. 2018) have shown a progressive significant reduc-
tion of SS values after successful TIPS implantation.
When considering all such data, we have hypothe-
sized that a non-invasive assessment of SS, alone or
combined with CDUS findings, would provide a useful
predictive value in evaluating TIPS function.
The first relevant result of our study is that SS, as
estimated by pSWE, is feasible for most patients with
portal hypertension, which differs from TE, which has
shown a high rate of unreliable measurements and fail-
ures mainly because of the presence of ascites. Second,
we have obtained a good inter-observer agreement for
SS measurements, as expressed by a high ICC of 0.90.
The optimal feasibility and good reproducibility of
pSWE, also in patients with ascites, is an important
achievement for clinical practitioners.
Assessing TIPS dysfunction by spleen elastography and Doppler ultrasound M. GIUNTA et al. 1649Moreover, we have achieved interesting results by
analyzing spleen elastographic measurements. At vari-
ance from mean LS values, the mean SS values signifi-
cantly decreased after TIPS placement. An explanation
of this finding can be the presence of the stent inside the
hepatic parenchyma, which can create, at least in the
very first 24-h period, a kind of compression leading to
increased LS. It is also plausible that TIPS placement
has more impact on the reduction of venous congestion
in the spleen than in the liver because of the inherent
hemodynamic differences between the two organs. The
reduction of mean SS after TIPS placement/revision sup-
ports the idea that SS reflects the portal vein pressure
better than LS. Our data shows that, in the whole group
of 49 examinations, SS values significantly and posi-
tively correlated with HVPG/PPG values, whereas LS
values did not. The absence of a significant correlation
between LS and HVPG is in line with previous data
from the literature, according to which, when HVPG val-
ues exceed 10‒12 mm Hg (which is the threshold of clin-
ically significant portal hypertension and varices
development) the portal pressure becomes largely inde-
pendent from liver fibrosis: therefore, the ability of LS to
predict HVPG is not optimal, while SS better reflects the
hemodynamic changes that occur in cirrhotic patients
(Hirooka et al. 2011; Stefanescu et al. 2011).
The most interesting results of this study have
emerged from the multivariate analysis results. Among
all the CDUS parameters, the most accurate one was the
flow direction in the intrahepatic portal vein branches,
while among the elastographic data the best parameter
was SS as measured by pSWE.
As concerns the CDUS parameters, the finding of a
reversal of the blood flow direction (from hepatofugal to
hepatopetal) within the intrahepatic portal vein branches,
as a relevant predictor of TIPS dysfunction, is in line
with previous data (Albrades et al. 2005). Interestingly,
the performance of other CDUS parameters (i.e. direc-
tion and flow velocity of the main portal vein and flow
velocity in the shunt, proximal and distal), more difficult
to obtain and less reproducible, was not significantly
related to TIPS function.
Both the flow direction within the intrahepatic por-
tal vein branches and SS values have shown very good
positive and negative likelihood ratios (LR) for TIPS
dysfunction.
From our data, the best cutoff value of SS, to maxi-
mize sensitivity and specificity, is 25 kPa with 86% sen-
sitivity and 92% specificity.
Of note, according to the multivariate analysis results,
combining the two parameters leads to an overall diagnos-
tic accuracy increase. In fact, the AUROC (0.86 for SS
alone) increased to 0.90 when the flow direction within the
intrahepatic portal vein branches was added to the model.The multivariate analysis has confirmed the strong
association between TIPS dysfunction with SS values
>25 kPa and a hepatopetal flow direction in the intrahe-
patic portal vein branches.
This study also has some limitations, such as the
relatively small sample size, which makes it difficult to
generalize our findings, and the lack of follow-up clini-
cal data on most of the patients participating in the study.
However, the data obtained is promising, and therefore
further studies on SS in large populations of patients
with TIPS dysfunction and long-term follow-up after
TIPS placement should be encouraged.
In conclusion, our results suggest that spleen pSWE
can be used quantitatively to assess SS as an indicator of
TIPS function. The assessment of the blood flow direc-
tion in the intrahepatic portal vein branches is a rapid
and easy parameter to obtain, and this is the best predic-
tor of TIPS dysfunction among the echo CDUS parame-
ters. The combination of the two simple parameters
(measured by CDUS and elastography), identified as
independent predictors of TIPS dysfunction at multivari-
ate analysis, is highly sensitive, which accurately enables
TIPS dysfunction to be ruled out.
Conflict of interest disclosure—The authors declare no competing
interests.
REFERENCES
Abraldes JG, Gilabert R, Turnes J, Nicolau C, Berzigotti A, Aponte J,
Bru C, Bosch J, Garcıa-Pagan JC. Utility of color Doppler ultraso-
nography predicting tips dysfunction. Am J Gastroenterol
2005;100:2696–2701.
Attia D, Rodt T, Marquardt S, Hinrichs J, Meyer BC, Gebel M, Wacker F,
Manns MP, Potthoff A. Shear wave elastography prior to transjugular
intrahepatic portosystemic shunt may predict the decrease in hepatic
vein pressure gradient. Abdom Radiol (NY) 2019;44:1127–1134.
Bland JM, Altman DG. Statistical methods for assessing agreement between
two methods of clinical measurement. Lancet 1986;1:307–310.
Boursier J, Konate A, Guilluy M, Gorea G, Sawadogo A, Quemener E,
Oberti F, Reaud S, Hubert-Fouchard I, Dib N, Cales P. Learning
curve and interobserver reproducibility evaluation of liver stiffness
measurement by transient elastography. Eur J Gastroenterol Hepa-
tol 2008;20:693–701.
Boyer TD, Haskal ZJ. American Association for the Study of Liver
Diseases practice guidelines: The role of transjugular intrahepatic
portosystemic shunt creation in the management of portal hyperten-
sion. J Vasc Interv Radiol 2005;16:615–629.
Buechter M, Manka P, Theysohn JM, Reinboldt M, Canbay A, Kahra-
man A. Spleen stiffness is positively correlated with HVPG and
decreases significantly after TIPS implantation. Dig Liver Dis
2018;50(1):54–60 Jan.
Calvaruso V, Bronte F, Conte E, Simone F, Craxı A, Di Marco V. Modified
spleen stiffness measurement by transient elastography is associated
with presence of large oesophageal varices in patients with compensated
hepatitis C virus cirrhosis. J Viral Hepat 2013;20:867–874.
Casado M, Bosch J, Garcıa-Pagan JC, Bru C, Ba~nares R, Bandi JC,
Escorsell A, Rodrıguez-Laiz JM, Gilabert R, Feu F, Schorlemer C,
Echenagusia A, Rodes J. Clinical events after transjugular intrahe-
patic portosystemic shunt: Correlation with hemodynamic findings.
Gastroenterology 1998;114:1296–1303.
Cello JP, Ring EJ, Olcott EW, Koch J, Gordon R, Sandhu J, Morgan
DR, Ostroff JW, Rockey DC, Bacchetti P, LaBerge J, Lake JR,
Somberg K, Doherty C, Davila M, McQuaid K, Wall SD.
1650 Ultrasound in Medicine & Biology Volume 46, Number 7, 2020Endoscopic sclerotherapy compared with percutaneous transjugular
intrahepatic portosystemic shunt after initial sclerotherapy in
patients with acute variceal hemorrhage: A randomized, controlled
trial. Ann Intern Med 1997;126:858–865.
Chong WK, Malisch TA, Mazer MJ, Lind CD, Worrell JA, Richards
WO. Transjugular intrahepatic portosystemic shunt: US assessment
with maximum flow velocity. Radiology 1993;189:789–793.
Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A,
Casazza G, Schiumerini R, Turco L, Di Biase AR, Mazzella G,
Marzi L, Arena U, Pinzani M, Festi D. Measurement of spleen stiff-
ness to evaluate portal hypertension and the presence of esophageal
varices in patients with HCV-related cirrhosis. Gastroenterology
2012;143:646–654.
De Santis A, Nardelli S, Bassanelli C, Lupo M, Iegri C, Di Ciesco CA,
Forlino M, Farcomeni A, Riggio O. Modification of splenic stiff-
ness on acoustic radiation force impulse parallels the variation of
portal pressure induced by transjugular intrahepatic portosystemic
shunt. J Gastroenterol Hepatol 2018;33:704–709.
Fagiuoli S, Bruno R, Debernardi Venon W, Schepis F, Vizzutti F, Toniutto
P, Senzolo M, Caraceni P, Salerno F, Angeli P, Cioni R, Vitale A,
Grosso M, De Gasperi A, D’Amico G, Marzano A, AISF TIPS Special
Conference. Consensus conference on TIPS management: Techniques,
indications, contraindications. Dig Liver Dis 2017;49:121–137.
Feldstein VA, LaBerge JM. Hepatic vein flow reversal at duplex
sonography: A sign of transjugular intrahepatic portosystemic
shunt dysfunction. AJR 1994;162:839–841.
Ferral H, Foshager MC, Bjarnason H, Finlay DE, Hunter DW, Casta-
~neda-Zu~niga WR, Letourneau JG. Early sonographic evaluation of
the transjugular intrahepatic portosystemic shunt (TIPS). Cardio-
vasc Intervent Radiol 1993;16:275–279.
Fleiss JL. The design and analysis of clinical experiments. New York:
John Wiley and Sons; 1986.
Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G,
Colombo M. Reproducibility of transient elastography in the evalu-
ation of liver fibrosis in patients with chronic liver disease. Gut
2007;56:968–973.
Fraquelli M, Giunta M, Pozzi R, Rigamonti C, Della Valle S, Massir-
oni S, Conti CB, Aghemo A, Ronchi G, Iurlo A, Primignani M,
Conte D, Colombo M. Feasibility and reproducibility of spleen
transient elastography and its role in combination with liver tran-
sient elastography for predicting the severity of chronic viral hepa-
titis. J Viral Hepat 2014;21:90–98.
Foshager MC, Ferral H, Nazarian GK, Casta~neda-Zu~niga WR, Letour-
neau JG. Duplex sonography after transjugular intrahepatic portosyste-
mic shunts (TIPS): Normal hemodynamic findings and efficacy in
predicting shunt patency and stenosis. Am Roentgenol 1995;165:1–7.
Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE,
Glickman M. Portal pressure, presence of gastroesophageal varices
and variceal bleeding. Hepatology 1985;5:419–424.
Gao J, Ran HT, Ye XP, Zheng YY, Zhang DZ, Wang ZG. The stiffness
of the liver and spleen on ARFI Imaging pre and post TIPS place-
ment: A preliminary observation. Clin Imaging 2012;36:135–141.
Gao J, Zheng X, Zheng YY, Zuo GQ, Ran HT, Auh YH, Waldron L,
Chan T, Wang ZG. Shear wave elastography of the spleen for mon-
itoring transjugular intrahepatic portosystemic shunt function: A
pilot study. J Ultrasound Med 2016;35:951–958.
Han H, Yang J, Zhuge YZ, Zhang M, Wu M. Point shear wave elastog-
raphy to evaluate and monitor changing portal venous pressure in
patients with decompensated cirrhosis. Ultrasound Med Biol
2017;43:1134–1140.
Hirooka M, Ochi H, Koizumi Y, Kisaka Y, Abe M, Ikeda Y, Matsuura
B, Hiasa Y, Onji M. Splenic elasticity measured with real-timetissue elastography is a marker of portal hypertension. Radiology
2011;261:960–968.
Kanterman RY, Darcy MD, Middleton WD, Sterling KM, Teefey SA,
Pilgram TK. Doppler sonography findings associated with transju-
gular intrahepatic portosystemic shunt malfunction. AJR Am J
Roentgenol 1997;168:467–472.
Longo JM, Bilbao JI, Rousseau HP, Garcıa-Villareal L, Vinel JP,
Zozaya JM. Transjugular intrahepatic portosystemic shunt:
Evaluation with Doppler sonography. Radiology 1993;186:529–
534.
Novelli PM, Cho K, Rubin JM. Sonographic assessment of spleen
stiffness before and after transjugular intrahepatic portosyste-
mic shunt placement with or without concurrent embolization
of portal systemic collateral veins in patients with cirrhosis and
portal hypertension: A feasibility study. J Ultrasound Med
2015;34:443–449.
Piecha F, Paech D, Sollors J, Seitz HK, R€ossle M, Rausch V, Mueller
S. Rapid change of liver stiffness after variceal ligation and TIPS
implantation. Am J Physiol Gastrointest Liver Physiol 2018;314:
G179–G187.
Ran HT, Ye XP, Zheng YY, Zhang DZ, Wang ZG, Chen J, Madoff D,
Gao J. Spleen stiffness and splenoportal venous flow: Assessment
before and after transjugular intrahepatic portosystemic shunt
placement. J Ultrasound Med 2013;32:221–228.
R€ossle M, Haag K, Ochs A, Sellinger M, N€oldge G, Perarnau JM,
Berger E, Blum U, Gabelmann A, Hauenstein K. The transjugular
intrahepatic portosystemic stent-shunt procedure for variceal bleed-
ing. N Engl J Med 1994;330:165–171.
Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, 3rd, Shiffman ML,
Cole PE, Tisnado J, Simmons S. Transjugular intrahepatic porto-
systemic shunts compared with endoscopic sclerotherapy for the
prevention of recurrent variceal hemorrhage: A randomized, con-
trolled trial. Ann Intern Med 1997;126:849–857.
Sharma P, Kirnake V, Tyagi P, Bansal N, Singla V, Kumar A, Arora A.
Spleen stiffness in patients with cirrhosis in predicting esophageal
varices. Am J Gastroenterol 2013;108:1101–1107.
Singh S, Eaton JE, Murad MH, Tanaka H, Iijima H, Talwalkar JA.
Accuracy of spleen stiffness measurement in detection of
esophageal varices in patients with chronic liver disease: Sys-
tematic review and meta-analysis. Clin Gastroenterol Hepatol
2014;12:935–945.
Stefanescu H, Grigorescu M, Lupsor M, Procopet B, Maniu A, Badea
R. Spleen stiffness measurement using Fibroscan for the noninva-
sive assessment of esophageal varices in liver cirrhosis patients. J
Gastroenterol Hepatol 2011;26:164–170.
Stefanescu H, Procopet B, Platon Lupsor M. Modified spleen stiffness
measurement: A step forward, but still not the solution to all prob-
lems in the noninvasive assessment of cirrhotic patients. Letter to
editor; J Viral Hepat 2014;21(7):54.
Surratt RS, Middleton WD, Darcy MD, Melson GL, Brink JA. Mor-
phologic and hemodynamic findings at sonography before and after
creation of a transjugular intrahepatic portosystemic shunt. AJR
Am J Roentgenol 1993;160:627–630.
Wong GL, Liang LY, Kwok R, Hui AJ, Tse YK, Chan HL, Wong VW.
Low risk of variceal bleeding in patients with cirrhosis after vari-
ceal screening stratified by liver/spleen stiffness. Hepatology
2019;70:971–981.
Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F,
de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beau-
grand M. Noninvasive assessment of liver fibrosis by measure-
ment of stiffness in patients with chronic hepatitis C. Hepatology
2005;41:48–54.
